Annual Non Current Assets
$236.36 M
+$124.19 M+110.71%
December 31, 2023
Summary
- As of February 9, 2025, CERE annual long term assets is $236.36 million, with the most recent change of +$124.19 million (+110.71%) on December 31, 2023.
- During the last 3 years, CERE annual non current assets has risen by +$181.65 million (+332.00%).
Performance
CERE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Non Current Assets
$267.77 M
+$31.41 M+13.29%
March 31, 2024
Summary
- As of February 9, 2025, CERE quarterly long term assets is $267.77 million, with the most recent change of +$31.41 million (+13.29%) on March 31, 2024.
- Over the past year, CERE quarterly non current assets has increased by +$133.59 million (+99.56%).
Performance
CERE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
CERE Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +110.7% | +99.6% |
| 3 y3 years | +332.0% | +311.9% |
| 5 y5 years | +600.8% | +311.9% |
CERE Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -53.1% | at high | -78.9% |
| 5 y | 5-year | at high | -85.7% | at high | -79.6% |
| alltime | all time | at high | -85.7% | at high | -79.6% |
Cerevel Therapeutics Holdings Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $267.77 M(+13.3%) |
| Dec 2023 | $1.01 B(+11.2%) | $236.36 M(+76.2%) |
| Sep 2023 | - | $134.18 M(-6.0%) |
| Jun 2023 | - | $142.68 M(+59.3%) |
| Mar 2023 | - | $89.56 M(-20.2%) |
| Dec 2022 | $905.65 M | $112.17 M(+18.0%) |
| Sep 2022 | - | $95.05 M(+68.2%) |
| Jun 2022 | - | $56.52 M(-13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $65.00 M(-41.4%) |
| Dec 2021 | $578.02 M(+48.0%) | $110.90 M(+89.7%) |
| Sep 2021 | - | $58.45 M(-1.3%) |
| Jun 2021 | - | $59.22 M(+1.6%) |
| Mar 2021 | - | $58.29 M(+6.5%) |
| Dec 2020 | $390.56 M(+348.5%) | $54.71 M(-63.4%) |
| Sep 2020 | - | $149.57 M |
| Dec 2019 | $87.08 M | - |
FAQ
- What is Cerevel Therapeutics Holdings annual long term assets?
- What is the all time high annual non current assets for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual non current assets year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly long term assets?
- What is the all time high quarterly non current assets for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly non current assets year-on-year change?
What is Cerevel Therapeutics Holdings annual long term assets?
The current annual non current assets of CERE is $236.36 M
What is the all time high annual non current assets for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual long term assets is $236.36 M
What is Cerevel Therapeutics Holdings annual non current assets year-on-year change?
Over the past year, CERE annual long term assets has changed by +$124.19 M (+110.71%)
What is Cerevel Therapeutics Holdings quarterly long term assets?
The current quarterly non current assets of CERE is $267.77 M
What is the all time high quarterly non current assets for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly long term assets is $267.77 M
What is Cerevel Therapeutics Holdings quarterly non current assets year-on-year change?
Over the past year, CERE quarterly long term assets has changed by +$133.59 M (+99.56%)